TradeLink Capital’s Exact Sciences EXAS Stock Holding History

TradeLink Capital’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-5,000	Closed	-$433K	–	20
2019 Q1	$433K	Buy	+5,000	New	+$426K	2.3%	9

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TradeLink Capital's EXAS Position: Q2 2019 in Review

TradeLink Capital sold out of Exact Sciences (EXAS) in Q2 2019, closing a stake of 5,000 shares — an estimated $433K sold.

TradeLink Capital first reported a position in EXAS in Q1 2019 and held it in 1 quarter. The position peaked at $433K in Q1 2019. 472 funds tracked by Wall St. Rank hold EXAS as of Q2 2019.

TradeLink Capital reported no remaining Exact Sciences position as of Q2 2019 after selling out during the quarter.
TradeLink Capital sold 5,000 Exact Sciences shares in Q2 2019, an estimated $433K.
TradeLink Capital first reported a position in Exact Sciences in Q1 2019 and held it in 1 quarter.
TradeLink Capital's Exact Sciences position peaked at $433K in Q1 2019.
472 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2019.

Based on TradeLink Capital's 13F filing for Q2 2019, filed 31 Jul 2019.